Home Tags Eli Lilly

Tag: Eli Lilly

Nicole Smith-Holt from Richfield, MN holds a vial with the ashes of her son Alec, who died at the age of 26 from insulin rationing, during a protest against the high price of insulin outside the offices of drug giant Sanofi in Cambridge, MA on Nov. 16, 2018.

The incredible history of insulin, a lifesaving diabetes drug that was discovered almost a century ago and is now at the center of drug pricing outrag...

How a drug that was discovered 95 years ago changed the way we treat diabetes — and why it's so expensive today.

Dispensed: Change at the FDA, insurance startup financials for 2018, and the first new depression drug in 35 years

Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
A Type 1 diabetes patient holds up bottles of insulin including Humalog. Lilly is now offering its insulin as an authorized generic at half the list price of the branded version.

A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political ...

Eli Lilly plans to make a generic version of its life-saving diabetes medication Humalog and sell it for half the price of the branded drug.

We’ll get you caught up on all the news you missed at the year’s biggest healthcare investor conference

Among the highlights: an $8 billion deal (and more to come?), a promising depression drug, and a strategy deep dive from a healthcare giant.

Dispensed: What we saw at JPMorgan’s big healthcare investor conference

Welcome to Dispensed: A weekly dose of pharma, biotech, and healthcare news.
Eli Lilly announced early Monday that it plans to buy the biotech Loxo Oncology for about $8 billion.

Pharma giant Eli Lilly just made an $8 billion bet on a cutting-edge scientific approach that uses DNA to treat cancer

Eli Lilly's $8 billion acquisition of the biotech company Loxo Oncology is a notably large deal, but it's open to additional ones, its CEO said.

Eli Lilly stock gets bump after positive results for its mid-stage diabetes drug trial

On Thursday, pharma giant Eli Lilly and Co. announced positive results in a mid-stage trial for its experimental new diabetes drug. The company's stock was up 3% in afternoon trading.
An illustration of a man suffering from a migraine.

Drugmakers are using an unusual tactic to compete in a new class of medication treating the 38 million Americans who have migraines

Until May, there weren't any FDA-approved drugs available for alleviating migraines, though other treatments — including Botox and anti-seizure medications — have been used. Pain relievers can also help treat some of the symptoms of migraines.
A human brain and its millions of small nerves

A new migraine medication that’s changing the way we treat a condition that affects 38 million Americans just got approved

The FDA just approved a new preventative migraine medication made by drug giant Eli Lilly. The drug, Emgality, is the third in a competitive new class of medication going after the 38 million Americans who have migraines.